Impax Laboratories, Inc.
http://www.impaxlabs.com/
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Impax Laboratories, Inc.
Liquid Biopsy Revolutionizing Cancer Care, But Costs Continue To Inhibit Global Potential
Liquid biopsy represents potential advantages over traditional approaches to cancer surveillance, treatment selection and recurrence monitoring. But one size does not fit all, requiring tailored solutions for less developed markets.
Liquid Biopsy Revolutionizing Cancer Care, But Costs Continue To Inhibit Global Potential
Liquid biopsy represents potential advantages over traditional approaches to cancer surveillance, treatment selection and recurrence monitoring. But one size does not fit all, requiring tailored solutions for less developed markets.
Illumina Settles BGI Patent Battles For $325M
The settlement resolves a total of eight lawsuits between the companies on genetic sequencing technology and alleged antitrust violations.
Jury Sides With Endo And Impax On 2014 Opana Antitrust Suit
Endo and Impax have received a favorable jury verdict after a 2010 patent-litigation settlement between the pair over Endo’s Opana ER was alleged to have been “an anticompetitive scheme that restrained competition,”
Company Information
- Industry
-
Pharmaceuticals
- Generic Drugs
- Specialty Pharmaceuticals
-
Drug Delivery
- Controlled Release
- Other Names / Subsidiaries
-
- Amedra Pharmaceuticals LLC
- CorePharma LLC
- Impax Generics
- Impax Specialty Pharma
- Lineage Therapeutics Inc.
- Tower Holdings, Inc.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice